MoneyWorks4Me

NATCO Pharma informs about issuance of duplicate share certificates

27 Feb 2023 Evaluate

Pursuant to the Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 NATCO Pharma has informed that the company is in process of issuing duplicate share certificates in lieu of the originals thereof, stated to have been lost by the respective shareholder, Sumer Kawar (Folio No: 19358), further details are attached.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..